Yamashita K - Search Results

1

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M, Sato F, Meltzer SJ, Sidransky D. Yamashita K, et al. Cancer Cell. 2002 Dec;2(6):485-95. doi: 10.1016/s1535-6108(02)00215-5. Cancer Cell. 2002. PMID: 12498717 Free article.

2

Localization of thymidine phosphorylase expression in colorectal carcinoma tissues by in situ RT-PCR assay.

Mimori K, Matsuyama A, Yoshinaga K, Yamashita K, Masuda T, Inoue H, Ueo H, Mori M. Mimori K, et al. Among authors: yamashita k. Oncology. 2002;62(4):327-32. doi: 10.1159/000065064. Oncology. 2002. PMID: 12138240

3

Clinical significance of the expression of activin A in esophageal carcinoma.

Yoshinaga K, Mimori K, Yamashita K, Utsunomiya T, Inoue H, Mori M. Yoshinaga K, et al. Among authors: yamashita k. Int J Oncol. 2003 Jan;22(1):75-80. Int J Oncol. 2003. PMID: 12469187

4

Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.

Yamashita K, Upadhay S, Mimori K, Inoue H, Mori M. Yamashita K, et al. Cancer. 2003 May 15;97(10):2412-9. doi: 10.1002/cncr.11368. Cancer. 2003. PMID: 12733139 Free article.

5

MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway.

Mimori K, Shiraishi T, Mashino K, Sonoda H, Yamashita K, Yoshinaga K, Masuda T, Utsunomiya T, Alonso MA, Inoue H, Mori M. Mimori K, et al. Among authors: yamashita k. Oncogene. 2003 May 29;22(22):3463-71. doi: 10.1038/sj.onc.1206378. Oncogene. 2003. PMID: 12776198

6

Re: Is TIG1 a new tumor suppressor in prostate cancer?

Tokumaru Y, Sun DI, Nomoto S, Yamashita K, Sidransky D. Tokumaru Y, et al. Among authors: yamashita k. J Natl Cancer Inst. 2003 Jun 18;95(12):919-20. doi: 10.1093/jnci/95.12.919. J Natl Cancer Inst. 2003. PMID: 12813179 No abstract available.

7

High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array.

Hoque MO, Lee J, Begum S, Yamashita K, Engles JM, Schoenberg M, Westra WH, Sidransky D. Hoque MO, et al. Among authors: yamashita k. Cancer Res. 2003 Sep 15;63(18):5723-6. Cancer Res. 2003. PMID: 14522891

8

A tumor-suppressive role for trypsin in human cancer progression.

Yamashita K, Mimori K, Inoue H, Mori M, Sidransky D. Yamashita K, et al. Cancer Res. 2003 Oct 15;63(20):6575-8. Cancer Res. 2003. PMID: 14583448

9

Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.

Yamashita K, Tanaka Y, Mimori K, Inoue H, Mori M. Yamashita K, et al. Int J Cancer. 2004 Jun 10;110(2):201-7. doi: 10.1002/ijc.20067. Int J Cancer. 2004. PMID: 15069682

10

Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma.

Tokumaru Y, Harden SV, Sun DI, Yamashita K, Epstein JI, Sidransky D. Tokumaru Y, et al. Among authors: yamashita k. Clin Cancer Res. 2004 Aug 15;10(16):5518-22. doi: 10.1158/1078-0432.CCR-04-0108. Clin Cancer Res. 2004. PMID: 15328191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,602 results

Search Page

Filters